Fragment / Modified GRF / Ipamorelin 12 mg
- Active Substance: HGH Fragment 176-191 (6 mg), Modified GRF (CJC-1295 No DAC, 3 mg), Ipamorelin (3 mg)
- Concentration: 12 mg per vial (6 mg HGH Fragment 176-191 + 3 mg Modified GRF + 3 mg Ipamorelin)
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Peptide Blend
- Molecular Formula (HGH Fragment 176-191): C78H125N24O24S2
- Molecular Weight (HGH Fragment 176-191): 1817.12 g/mol
- Sequence (HGH Fragment 176-191): Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
- Molecular Formula (Modified GRF): C152H252N44O42
- Molecular Weight (Modified GRF): 3367.97 g/mol
- Sequence (Modified GRF): H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
- Molecular Formula (Ipamorelin): C38H49N9O5
- Molecular Weight (Ipamorelin): 711.85 g/mol
- Sequence (Ipamorelin): Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Synonyms: HGH Fragment 176-191 (AOD9604), Modified GRF (CJC-1295 No DAC), Ipamorelin (GHRP, Ghrelin mimetic)
Fragment / Modified GRF / Ipamorelin 12 mg – Vanguard of Metabolic Excellence
Product Summary
Envision a research frontier where fat dissolves, muscles flourish, and vitality thrives. Fragment / Modified GRF / Ipamorelin 12 mg vial from Peptide Sciences USA leads this charge. This tri-peptide blend harnesses HGH Fragment's fat-burning precision, Modified GRF's sustained GH stimulation, and Ipamorelin's selective GH release, offering a premier tool for driving metabolic research forward.
How Fragment / Modified GRF / Ipamorelin Works
This tri-peptide blend unites HGH Fragment 176-191 (sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe), Modified GRF (CJC-1295 No DAC, sequence: H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2), and Ipamorelin (sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2). HGH Fragment mimics the C-terminal region of human growth hormone, promoting lipolysis and reducing fat mass by up to 14% in obese mice models without affecting glucose. Modified GRF binds to GHRH receptors, boosting GH and IGF-1 levels by 200–1000% for up to 6 days. Ipamorelin, a ghrelin mimetic, activates GHS-R1a receptors, inducing GH release within 2 hours without elevating cortisol or prolactin.
Their synergy enhances fat loss, muscle repair, and anti-aging effects. Preclinical studies show HGH Fragment targets adipose tissue, Modified GRF supports muscle hypertrophy and bone health, and Ipamorelin minimizes side effects while promoting recovery. This blend is ideal for researching body composition, fat metabolism, and anti-aging, with applications in metabolic health and tissue regeneration.
Why Choose Fragment / Modified GRF / Ipamorelin 12 mg?
This tri-peptide blend is a trailblazer for fat loss and anti-aging research, offering synergistic benefits. Here's why it excels:
- Targeted Fat Loss: HGH Fragment reduces fat mass by up to 14% in preclinical models, ideal for body composition studies.
- Muscle Growth: Modified GRF and Ipamorelin boost GH and IGF-1 levels, promoting muscle hypertrophy and protein synthesis.
- Enhanced Recovery: Accelerates muscle and tissue repair, minimizing recovery time in injury models.
- Anti-Aging Benefits: Improves skin elasticity, sleep quality, and metabolic health, supporting longevity research.
- Unmatched Quality: Peptide Sciences USA guarantees 99% purity through advanced synthesis, ensuring reliable research outcomes.
Fragment / Modified GRF / Ipamorelin 12 mg empowers researchers to drive metabolic research forward, backed by cutting-edge peptide science.
Product Specifications
Peptide Sciences USA's Fragment / Modified GRF / Ipamorelin 12 mg vial is crafted for precision in metabolic research, delivering exceptional quality. Here's the breakdown:
- Composition: Contains 12 mg total (6 mg HGH Fragment 176-191, C78H125N24O24S2, 1817.12 g/mol; 3 mg Modified GRF, C152H252N44O42, 3367.97 g/mol; 3 mg Ipamorelin, C38H49N9O5, 711.85 g/mol).
- Pack Size: Single vial of lyophilized powder, requiring reconstitution for subcutaneous injection.
- Manufacturing: Produced by Peptide Sciences USA with 99% purity, verified by High-Performance Liquid Chromatography and Mass Spectrometry.
- Usage Guidelines: Reconstitute with bacteriostatic water and administer subcutaneously, typically at 200–600 mcg HGH Fragment, 100–300 mcg Modified GRF, and 100–300 mcg Ipamorelin daily, ideally at night or post-workout, in research protocols. Use under professional supervision.
- Storage: Store lyophilized powder at -20°C for long-term stability or 4°C for short-term use (up to 3–4 weeks). After reconstitution, refrigerate at 2–8°C and use within 30 days.
- Safety: Preclinical studies report mild side effects like injection site irritation or headaches; Ipamorelin's selectivity minimizes cortisol/prolactin effects. Limited human data requires research oversight.
This peptide blend is for research purposes only, providing a robust platform for studying fat loss and growth hormone optimization.
Legal Disclaimer
Fragment / Modified GRF / Ipamorelin 12 mg is supplied for research purposes only and is not FDA-approved for human use. It is banned by the World Anti-Doping Agency (WADA) for performance-enhancing use. It is not intended to diagnose, treat, cure, or prevent any condition. Consult a licensed professional before use. Peptide Sciences USA assumes no liability for misuse. All information is educational and based on preclinical research.
Frequently Asked Questions
What is the purpose of the Fragment / Modified GRF / Ipamorelin 12 mg blend in research?
The blend is used to investigate fat loss, growth hormone stimulation, muscle growth, and anti-aging effects, focusing on lipolysis and tissue repair in preclinical models.
What benefits does the Fragment / Modified GRF / Ipamorelin 12 mg blend offer in studies?
It reduces fat mass by up to 14%, enhances muscle growth, speeds recovery, and improves sleep and skin elasticity, ideal for metabolic and anti-aging research.
Are there side effects with the Fragment / Modified GRF / Ipamorelin 12 mg blend?
Preclinical studies report mild side effects like injection site irritation or headaches. Ipamorelin's selectivity minimizes cortisol/prolactin effects, but oversight is needed.
How is the Fragment / Modified GRF / Ipamorelin 12 mg blend administered in research?
The 12 mg vial is reconstituted with bacteriostatic water and injected subcutaneously at 200–600 mcg Fragment, 100–300 mcg Mod GRF, and 100–300 mcg Ipamorelin daily.
How should the Fragment / Modified GRF / Ipamorelin 12 mg vial be stored?
Store lyophilized powder at -20°C or 4°C for up to 3–4 weeks. After reconstitution, refrigerate at 2–8°C and use within 30 days to maintain potency.
Related Products
- Active Substance: Epitalon
- Concentration: 50 mg per vial
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Epitalon
- Molecular Formula: C14H22N4O9
- Molecular Weight: 390.35 g/mol
- Sequence: Ala-Glu-Asp-Gly
- Synonyms: Epithalon, AEDG, Epithalamin analog
- Active Substance: Proxofim (FOXO4-D-Retro-Inverso)
- Concentration: 10 mg per vial
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Proxofim
- Molecular Formula: C228H388N86O64
- Molecular Weight: 5358.05 g/mol
- Sequence: H-D-Leu-D-Thr-D-Leu-D-Arg-D-Lys-D-Glu-D-Pro-D-Ala-D-Ser-D-Glu-D-Ile-D-Ala-D-Gln-D-Ser-D-Ile-D-Leu-D-Glu-D-Ala-D-Tyr-D-Ser-D-Gln-D-Asn-D-Gly-D-Trp-D-Ala-D-Asn-D-Arg-D-Arg-D-Ser-D-Gly-D-Gly-D-Lys-D-Arg-D-Pro-D-Pro-D-Pro-D-Arg-D-Arg-D-Arg-D-Gln-D-Arg-D-Arg-D-Lys-D-Lys-D-Arg-D-Gly-OH
- Synonyms: Forkhead box protein O4 D-Retro-Inverso, FOXO4a, AFX, AFX1, MLLT7
- Active Substance: HGH Fragment 176-191 (6 mg), Modified GRF (CJC-1295 No DAC, 3 mg), Ipamorelin (3 mg)
- Concentration: 12 mg per vial (6 mg HGH Fragment 176-191 + 3 mg Modified GRF + 3 mg Ipamorelin)
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Peptide Blend
- Molecular Formula (HGH Fragment 176-191): C78H125N24O24S2
- Molecular Weight (HGH Fragment 176-191): 1817.12 g/mol
- Sequence (HGH Fragment 176-191): Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
- Molecular Formula (Modified GRF): C152H252N44O42
- Molecular Weight (Modified GRF): 3367.97 g/mol
- Sequence (Modified GRF): H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
- Molecular Formula (Ipamorelin): C38H49N9O5
- Molecular Weight (Ipamorelin): 711.85 g/mol
- Sequence (Ipamorelin): Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Synonyms: HGH Fragment 176-191 (AOD9604), Modified GRF (CJC-1295 No DAC), Ipamorelin (GHRP, Ghrelin mimetic)
- Active Substance: HGH Fragment 176-191 (6 mg), CJC1295 No DAC (3 mg), Ipamorelin (3 mg)
- Concentration: 12 mg per vial (6 mg HGH Fragment 176-191 + 3 mg CJC1295 + 3 mg Ipamorelin)
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Peptide Blend
- Molecular Formula (HGH Fragment 176-191): C78H125N24O24S2
- Molecular Weight (HGH Fragment 176-191): 1817.12 g/mol
- Sequence (HGH Fragment 176-191): Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
- Molecular Formula (CJC1295 No DAC): C152H252N44O42
- Molecular Weight (CJC1295 No DAC): 3367.97 g/mol
- Sequence (CJC1295 No DAC): H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
- Molecular Formula (Ipamorelin): C38H49N9O5
- Molecular Weight (Ipamorelin): 711.85 g/mol
- Sequence (Ipamorelin): Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Synonyms: HGH Fragment 176-191 (AOD9604), CJC1295 No DAC (Mod GRF), Ipamorelin (GHRP, Ghrelin mimetic)
- Active Substance: Tripeptide-1 (Glycyl-L-Histidyl-L-Lysine)
- Concentration: 200 mg per vial
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: GHK Basic
- Molecular Formula: C14H24N6O4
- Molecular Weight: 340.38 g/mol
- Sequence: Gly-His-Lys
- Synonyms: GHK, Glycyl-L-Histidyl-L-Lysine, Tripeptide-1